[144] SOPHiA GENETICS SA SEC Filing

Rhea-AI Filing Summary

SOPHiA GENETICS SA (SOPH) Form 144 notice discloses a proposed sale of 10,415 common shares through Morgan Stanley Smith Barney on 09/26/2025 with an aggregate market value of $35,723.45. The shares were acquired as founders' shares on 03/18/2011. The filing also lists multiple recent dispositions by the same person, including several 10b5-1 plan sales and one direct sale of 40,829 shares on 08/19/2025. Total shares reported sold in the past three months sum to 83,725 shares. The filer affirms no undisclosed material adverse information and references compliance with Rule 10b5-1 where applicable.

Positive

• Disclosure compliance: Filing provides required details on proposed sale and recent dispositions, supporting regulatory transparency
• Use of Rule 10b5-1 plans: Several sales are identified as executed under 10b5-1 plans, indicating preplanned trading activity

Negative

• Insider selling activity: The filer sold 83,725 shares in the past three months, including a 40,829 share sale on 08/19/2025, increasing share supply
• Founder share liquidation: The proposed sale and prior disposals are of founder shares originally acquired on 03/18/2011, indicating owner liquidity rather than new issuance

Insights

Securities Analyst

TL;DR: Insider disposing of founder shares via scheduled plans and ad-hoc sale; recent three‑month sales total 83,725 shares.

The filing details a forthcoming sale of 10,415 common shares and documents multiple recent sales executed partly under a Rule 10b5-1 plan. The largest single reported sale was 40,829 shares on 08/19/2025. These transactions are quantitatively modest versus the reported 67,579,560 shares outstanding, but they represent ongoing insider liquidity. The inclusion of 10b5-1 sales suggests prearranged trading activity for some transactions, which may reduce concerns about opportunistic timing but still increases share availability in the market. All statements are procedural and do not disclose operational or financial results.

Corporate Governance Specialist

TL;DR: Filing shows compliance with disclosure rules and an insider certification of no undisclosed material information.

The filer signs the standard representation attesting no material nonpublic information and indicates reliance on Rule 10b5-1 for several sales where applicable. Documentation of the acquisition as founders' shares clarifies the origin of the holdings being sold. The filing is a routine insider disclosure that provides transparency about planned and recent dispositions, supporting governance and market transparency requirements rather than signaling corporate operational change.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10415	35723.45	67579560	09/26/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2011	Founders Shares	Issuer			10415	03/18/2011	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	09/23/2025	1300	5201.04
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	09/19/2025	4486	14547.65
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	08/19/2025	4487	15380.99
JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	08/19/2025	40829	142493.21
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/23/2025	769	2711.19
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/22/2025	2622	9397.25
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/21/2025	1864	6618.50
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/08/2025	15102	50390.84
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/07/2025	9600	28887.36
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/03/2025	2666	7946.28

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does SOPH Form 144 disclose about the proposed sale?

The Form 144 reports a proposed sale of 10,415 common shares via Morgan Stanley Smith Barney on 09/26/2025 with an aggregate market value of $35,723.45.

Who is the seller identified in the filing?

The filing identifies sales by Jurgi Camblong (address listed) and sales executed under 10b5-1 plans for his account.

How many shares were sold by the insider in the past three months?

The filing lists transactions totaling 83,725 shares sold in the past three months, with gross proceeds reported per sale.

Were any sales executed under a Rule 10b5-1 plan?

Yes. Several transactions are labeled as 10b5-1 sales, indicating they were executed under prearranged trading plans.

When and how were the shares being sold originally acquired?

The shares to be sold were acquired as Founders Shares on 03/18/2011 from the issuer.